Here’s What’s Happening With States’ Efforts to Set Payment Limits for Drugs

  • Feb 27, 2025

    While the federal government has already set negotiated prices for the first round of drugs subject to the Medicare Drug Price Negotiation Program, states that have the authority to set upper payment limits (UPLs) for medications are inching toward doing so — despite a variety of complications. 

    On the state level, the authority to set UPLs for select drugs is wielded by prescription drug affordability boards (PDABs), which states across the country have created in recent years amid mounting frustration over rising drug costs. Not all PDABs are authorized to set UPLs, but among the five boards that do, Colorado and Maryland are the furthest along in the process. 

    Read more
    © 2024 MMIT
  • Leslie Small

    Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

The Latest
Meet Our Reporters

Meet Our Reporters

×